Baseline | Week 12 | Difference between before and after treatment | SES | SRM | ||||
---|---|---|---|---|---|---|---|---|
x - ± SD | x - ± SD | x - ± SD | P | T | 95% CI | |||
Primary bothersome symptom | 6.68 ± 1.88 | 4.04 ± 2.43 | 2.64 ± 2.03 | <0.001 | 6.49 | 1.80-3.48 | 1.40 | 1.30 |
Secondary bothersome symptom | 6.35 ± 2.15 | 3.99 ± 2.43 | 2.36 ± 2.27 | <0.001 | 5.21 | 1.42-3.30 | 1.10 | 1.04 |
ZRADSQ | 15.28 ± 7.86 | 9.72 ± 5.36 | 5.56 ± 7.35 | <0.001 | 3.78 | 2.52-8.60 | 0.70 | 0.76 |
SCORAD | 42.87 ± 14.38 | 26.04 ± 14.50 | 16.83 ± 15.85 | <0.001 | 5.31 | 10.29-23.38 | 1.17 | 1.06 |